Zhejiang Shengda Pharm (603079) — Cash Flow Quality Index
Zhejiang Shengda Pharm (603079) has a Cash Flow Quality Index of 2.91x as of September 2025. Operating cash flow of CN¥45.27 Million exceeds net income of CN¥15.53 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Shengda Pharm (603079) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Shengda Pharm Cash Flow Quality Index (2012–2025)
Historical Cash Flow Quality Index for Zhejiang Shengda Pharm across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Zhejiang Shengda Pharm to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Shengda Pharm (2012–2025)
Year-by-year earnings quality comparison for Zhejiang Shengda Pharm. For live market cap and the full company financial profile, see market cap of Zhejiang Shengda Pharm.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.23x | CN¥138.88 Million | CN¥62.16 Million | ▼ -43.7% |
| 2024 | 3.97x | CN¥147.88 Million | CN¥37.26 Million | ▲ +196.7% |
| 2022 | 1.34x | CN¥40.72 Million | CN¥30.44 Million | ▲ +29.0% |
| 2021 | 1.04x | CN¥74.46 Million | CN¥71.82 Million | ▼ -40.9% |
| 2020 | 1.75x | CN¥333.20 Million | CN¥189.97 Million | ▲ +13.1% |
| 2019 | 1.55x | CN¥58.55 Million | CN¥37.76 Million | ▼ -25.5% |
| 2018 | 2.08x | CN¥88.69 Million | CN¥42.58 Million | ▲ +58.6% |
| 2017 | 1.31x | CN¥95.33 Million | CN¥72.61 Million | ▲ +9.6% |
| 2016 | 1.20x | CN¥73.00 Million | CN¥60.94 Million | ▼ -29.9% |
| 2015 | 1.71x | CN¥148.07 Million | CN¥86.70 Million | ▲ +117.4% |
| 2014 | 0.79x | CN¥34.40 Million | CN¥43.79 Million | ▼ -59.3% |
| 2013 | 1.93x | CN¥105.28 Million | CN¥54.59 Million | ▼ -8.3% |
| 2012 | 2.10x | CN¥110.08 Million | CN¥52.36 Million | — |